ATE58554T1 - Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper. - Google Patents
Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper.Info
- Publication number
- ATE58554T1 ATE58554T1 AT85306493T AT85306493T ATE58554T1 AT E58554 T1 ATE58554 T1 AT E58554T1 AT 85306493 T AT85306493 T AT 85306493T AT 85306493 T AT85306493 T AT 85306493T AT E58554 T1 ATE58554 T1 AT E58554T1
- Authority
- AT
- Austria
- Prior art keywords
- human
- hybridom
- production
- monoclonal antibodies
- fusion partner
- Prior art date
Links
- 230000004927 fusion Effects 0.000 title abstract 2
- 210000004408 hybridoma Anatomy 0.000 abstract 2
- 210000000628 antibody-producing cell Anatomy 0.000 abstract 1
- 210000004754 hybrid cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/948—Microorganisms using viruses or cell lines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/673,370 US4693975A (en) | 1984-11-20 | 1984-11-20 | Human hybridroma fusion partner for production of human monoclonal antibodies |
| EP85306493A EP0182467B1 (de) | 1984-11-20 | 1985-09-12 | Menschlicher Hybridomfusionspartner zur Herstellung menschlicher monoklonaler Antikörper |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE58554T1 true ATE58554T1 (de) | 1990-12-15 |
Family
ID=24702377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85306493T ATE58554T1 (de) | 1984-11-20 | 1985-09-12 | Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4693975A (de) |
| EP (1) | EP0182467B1 (de) |
| JP (1) | JPS61128886A (de) |
| AT (1) | ATE58554T1 (de) |
| AU (1) | AU577745B2 (de) |
| CA (1) | CA1245581A (de) |
| DE (1) | DE3580654D1 (de) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1214123A (en) * | 1983-01-20 | 1986-11-18 | Masashi Matsui | Cell lines for use in the preparation of hybridoma cells |
| JPH0798000B2 (ja) * | 1987-05-23 | 1995-10-25 | 萩原 義秀 | ガン関連抗原特異的ヒト免疫グロブリン |
| US5001065A (en) * | 1987-05-27 | 1991-03-19 | Cetus Corporation | Human cell line and triomas, antibodies, and transformants derived therefrom |
| JPH0249597A (ja) * | 1988-04-27 | 1990-02-19 | Kimiyoshi Tsuji | モノクローナル抗体及びその利用方法 |
| CA2002067A1 (en) * | 1988-11-09 | 1990-05-09 | Tamotsu Fukuda | Parent cell line for producing human hybridomas |
| US6274552B1 (en) | 1993-03-18 | 2001-08-14 | Cytimmune Sciences, Inc. | Composition and method for delivery of biologically-active factors |
| US20010055581A1 (en) * | 1994-03-18 | 2001-12-27 | Lawrence Tamarkin | Composition and method for delivery of biologically-active factors |
| US7229841B2 (en) * | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
| US6407218B1 (en) * | 1997-11-10 | 2002-06-18 | Cytimmune Sciences, Inc. | Method and compositions for enhancing immune response and for the production of in vitro mabs |
| WO2005065121A2 (en) * | 2003-12-02 | 2005-07-21 | Cytimmune Sciences, Inc. | Methods and compositions for the production of monoclonal antibodies |
| WO2005072893A1 (en) * | 2004-01-28 | 2005-08-11 | Cytimmune Sciences, Inc. | Functionalized colloidal metal compositions and methods |
| CN105902559A (zh) | 2005-08-01 | 2016-08-31 | 俄亥俄州立大学研究基金会 | 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物 |
| WO2007033023A2 (en) | 2005-09-12 | 2007-03-22 | The Ohio State University Research Foundation | Compositions and methods for the diagnosis and therapy of bcl2-associated cancers |
| EP2514434B1 (de) | 2006-01-05 | 2015-10-21 | The Ohio State University Research Foundation | Verfahren auf Mikro-RNA-Basis zur Diagnose, Prognose und Behandlung von Lungenkrebs |
| JP5490413B2 (ja) | 2006-01-05 | 2014-05-14 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 膵内分泌腫瘍及び膵腺房腫瘍におけるマイクロrna発現異常 |
| EP2487254B1 (de) | 2006-01-05 | 2015-07-29 | The Ohio State University Research Foundation | Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose und Behandlung von festen Krebsen |
| ES2446362T3 (es) | 2006-03-20 | 2014-03-07 | The Ohio State University Research Foundation | Huellas de microARN durante megacariocipoyesis humana |
| EP2436787B1 (de) * | 2006-07-13 | 2016-01-20 | The Ohio State University Research Foundation | Micro-ARN-21 zur Diagnose von Darm Adenokarzinom mit schlechter Uberlebensprognose. |
| JP5426383B2 (ja) * | 2006-09-19 | 2014-02-26 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 慢性リンパ球性白血病におけるmiR−29およびmiR−181によって制御されるTCL1発現 |
| CA2667617A1 (en) | 2006-11-01 | 2008-05-08 | The Ohio State University Research Foundation | Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma |
| CN101627134B (zh) | 2007-01-31 | 2013-11-06 | 俄亥俄州立大学研究基金会 | 用于急性髓细胞白血病(aml)的诊断、预后和治疗的基于微rna的方法和组合物 |
| JP5690588B2 (ja) | 2007-06-08 | 2015-03-25 | アメリカ合衆国 | 肝細胞癌のサブタイプを決定し、肝癌幹細胞を検出するための方法 |
| US8053186B2 (en) | 2007-06-15 | 2011-11-08 | The Ohio State University Research Foundation | Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing |
| JP2010535782A (ja) | 2007-07-31 | 2010-11-25 | ズィ、オハイオウ、ステイト、ユーニヴァーサティ、リサーチ、ファウンデイシャン | Dnmt3a及びdnmt3bを標的にすることによるメチル化を元に戻す方法 |
| EP3293269A1 (de) | 2007-08-03 | 2018-03-14 | MUSC Foundation For Research Development | Menschliche monoklonale antikörper und verfahren zu ihrer herstellung |
| ES2570359T3 (es) | 2007-08-03 | 2016-05-18 | Univ Ohio State Res Found | Regiones ultraconservadas que codifican ARNnc |
| JP5770472B2 (ja) | 2007-08-22 | 2015-08-26 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイションThe Ohio State University Research Foundation | ヒト急性白血病におけるepha7及びerkリン酸化の調節解除を誘発するための方法及び組成物 |
| WO2009039502A1 (en) * | 2007-09-21 | 2009-03-26 | Cytimmune Sciences, Inc. | Nanotherapeutic colloidal metal compositions and methods |
| US20110014118A1 (en) * | 2007-09-21 | 2011-01-20 | Lawrence Tamarkin | Nanotherapeutic colloidal metal compositions and methods |
| CN102137927B (zh) | 2007-10-26 | 2014-03-12 | 俄亥俄州立大学研究基金会 | 鉴定脆性组氨酸三联体(Fhit)相互作用的方法及其用途 |
| EP2219458B1 (de) | 2007-11-08 | 2015-07-15 | Cytimmune Sciences, Inc. | Zusammensetzungen und verfahren für die erzeugung von antikörpern |
| AU2009257410B2 (en) | 2008-06-11 | 2014-03-06 | Fudan University | Use of miR-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy |
| CN102803511A (zh) | 2009-11-23 | 2012-11-28 | 俄亥俄州立大学 | 用于影响肿瘤细胞生长、迁移和侵袭的材料和方法 |
| US8493081B2 (en) * | 2009-12-08 | 2013-07-23 | Magna Closures Inc. | Wide activation angle pinch sensor section and sensor hook-on attachment principle |
| AU2011326032B2 (en) | 2010-11-12 | 2016-10-06 | The Ohio State University Research Foundation | Materials and methods related to microRNA-21, mismatch repair, and colorectal cancer |
| WO2012068147A1 (en) | 2010-11-15 | 2012-05-24 | The Ohio State University Research Foundation | Controlled release mucoadhesive systems |
| CA2828772A1 (en) | 2011-03-07 | 2012-09-13 | The Ohio State University | Mutator activity induced by microrna-155 (mir-155) links inflammation and cancer |
| US9249468B2 (en) | 2011-10-14 | 2016-02-02 | The Ohio State University | Methods and materials related to ovarian cancer |
| AU2012352265B2 (en) | 2011-12-13 | 2017-02-16 | Ohio State Innovation Foundation | Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis |
| CN105936932A (zh) | 2012-01-20 | 2016-09-14 | 俄亥俄州立大学 | 浸润性和预后的乳腺癌生物标志物标签 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2079313A (en) * | 1980-07-07 | 1982-01-20 | Nat Res Dev | Improvements in or relating to rat myeloma cell lines |
| CH652145A5 (de) * | 1982-01-22 | 1985-10-31 | Sandoz Ag | Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen. |
| US4529694A (en) * | 1982-04-16 | 1985-07-16 | The Children's Medical Center Corporation | Cell fusion |
| US4574116A (en) * | 1983-01-13 | 1986-03-04 | The Board Of Trustees Of The Leland Stanford Jr. University | Methods and cell lines for immortalization and monoclonal antibody production by antigen-stimulated B-lymphocytes |
| CA1214123A (en) * | 1983-01-20 | 1986-11-18 | Masashi Matsui | Cell lines for use in the preparation of hybridoma cells |
| JPS59169489A (ja) * | 1983-03-15 | 1984-09-25 | Otsuka Pharmaceut Co Ltd | ヒト培養株化細胞 |
| JPS6054687A (ja) * | 1983-07-19 | 1985-03-29 | スロ−ン−ケツタリング インステイテユ−ト フオ− キヤンサ− リサ−チ | ヒト モノクロ−ン抗体の製法 |
| DK172686A (da) * | 1985-04-22 | 1986-10-23 | Hybritech Inc | Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet |
-
1984
- 1984-11-20 US US06/673,370 patent/US4693975A/en not_active Expired - Fee Related
-
1985
- 1985-09-12 EP EP85306493A patent/EP0182467B1/de not_active Expired - Lifetime
- 1985-09-12 AT AT85306493T patent/ATE58554T1/de not_active IP Right Cessation
- 1985-09-12 DE DE8585306493T patent/DE3580654D1/de not_active Expired - Lifetime
- 1985-09-25 CA CA000491535A patent/CA1245581A/en not_active Expired
- 1985-10-02 JP JP60219985A patent/JPS61128886A/ja active Pending
- 1985-11-19 AU AU50078/85A patent/AU577745B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61128886A (ja) | 1986-06-16 |
| CA1245581A (en) | 1988-11-29 |
| EP0182467B1 (de) | 1990-11-22 |
| AU5007885A (en) | 1986-05-29 |
| DE3580654D1 (de) | 1991-01-03 |
| US4693975A (en) | 1987-09-15 |
| EP0182467A3 (en) | 1987-09-16 |
| AU577745B2 (en) | 1988-09-29 |
| EP0182467A2 (de) | 1986-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE58554T1 (de) | Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper. | |
| HK52589A (en) | Process for the production of human mono-clonal antibodies | |
| ATE26464T1 (de) | Rekombinante monoklonale antikoerper. | |
| AU5445680A (en) | Antibody production by rat myeloma cells | |
| AU567693B2 (en) | Human monoclonal antibodies against bacterial toxins | |
| JPS5695123A (en) | Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human prothymocyte cell | |
| ES2013338A6 (es) | Un procedimioento para la obtencion de una linea celular hibrida productora de un anticuerpo monoclonal que se une especificamente a una proteina de superficie celular de un fagocito. | |
| PT86792A (pt) | Monoclonal antibodies against melanoma-associated antigens hybrid cell lines producing these antibodies and use therefor | |
| JPS56103115A (en) | Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human t cell antigen | |
| EP0212403A3 (de) | Monoklonale Antikörper gegen mucinartige Differenzierungsantigene des Menschen | |
| SE8106528L (sv) | Framstellning av menskliga monoklonala antikroppar medelst menskliga hybridom | |
| AU545181B2 (en) | Hybridoma for producing monoclonal antibodies | |
| EP0161638A3 (en) | Monoclonal antibody and method for quantitation of immoglobulins using the same | |
| DE3581288D1 (de) | Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen. | |
| DE3485128D1 (de) | Zellinien verwendbar zur herstellung von hybridomazellen. | |
| ES8503371A1 (es) | Procedimiento para preparar nuevos anticuerpos de igg de raton con especificidad anti-interferon de humano | |
| KR860007275A (ko) | 모노클로날 항-알파-아밀라제 항체 및 그의 제법 | |
| ES8801945A1 (es) | Un procedimiento para la obtencion de anticuerpos monoclonales contra peptidos atriales natuureticos. | |
| EP0287397A3 (en) | Monoclonal antibody specific to human pancreatic phospholipase a2 | |
| DE3580524D1 (de) | Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen. | |
| RU98104739A (ru) | Штамм культивируемых клеток мышиной гибридомы, используемый для получения моноклональных антител к ядрышковому антигену, ассоциированному с клеточной пролиферацией | |
| EP0200554A3 (de) | Spezifische monoklonale Antikörper für Interleukin-2 der Maus produzierende Hybridome | |
| EP0287012A3 (de) | Monoklonaler Anti-R-Binder-Antikörper, Verfahren zu seiner Herstellung und seine Verwendung | |
| NO874799L (no) | Fremgangsmaate for fremstilling av monoklonale antistofferved dyrking av hybridom-cellelinjen lym-2. | |
| NO874798D0 (no) | Fremgangsmaate for fremstilling av monoklonale antistoffer ved dyrking av hybridom-cellelinjen lym-1. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |